Literature DB >> 26538277

Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection.

Sang Won Park1, Ranawaka A P M Perera, Pyoeng Gyun Choe, Eric H Y Lau, Seong Jin Choi, June Young Chun, Hong Sang Oh, Kyoung-Ho Song, Ji Hwan Bang, Eu Suk Kim, Hong Bin Kim, Wan Beom Park, Nam Joong Kim, Leo Lit Man Poon, Malik Peiris, Myoung Don Oh.   

Abstract

Plaque reduction neutralisation tests (PRNT), microneutralisation (MN), Middle East respiratory syndrome (MERS)-spike pseudoparticle neutralisation (ppNT) and MERS S1-enzyme-linked immunosorbent assay (ELISA) antibody titres were compared using 95 sera from 17 patients with MERS, collected two to 46 days after symptom onset. Neutralisation tests correlated well with each other and moderately well with S1 ELISA. Moreover to compare antigenic similarity of genetically diverse MERS-CoV clades, the response of four sera from two patients sampled at two time periods during the course of illness were tested by 90% PRNT. Genetically diverse MERS-CoV clades were antigenically homogenous.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26538277     DOI： 10.2807/1560-7917.ES.2015.20.41.30042

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  26 in total

1.  No Serologic Evidence of Middle East Respiratory Syndrome Coronavirus Infection Among Camel Farmers Exposed to Highly Seropositive Camel Herds: A Household Linked Study, Kenya, 2013.

Authors:  Peninah Munyua; Victor Max Corman; Austine Bitek; Eric Osoro; Benjamin Meyer; Marcel A Müller; Erik Lattwein; S M Thumbi; Rees Murithi; Marc-Alain Widdowson; Christian Drosten; M Kariuki Njenga
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

2.  Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference.

Authors:  Jennifer L McKimm-Breschkin; Shibo Jiang; David S Hui; John H Beigel; Elena A Govorkova; Nelson Lee
Journal:  Antiviral Res       Date:  2017-11-21       Impact factor: 5.970

Review 3.  Vaccines for the prevention against the threat of MERS-CoV.

Authors:  Lanying Du; Wanbo Tai; Yusen Zhou; Shibo Jiang
Journal:  Expert Rev Vaccines       Date:  2016-04-06       Impact factor: 5.217

4.  Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis).

Authors:  Vincent J Munster; Danielle R Adney; Neeltje van Doremalen; Vienna R Brown; Kerri L Miazgowicz; Shauna Milne-Price; Trenton Bushmaker; Rebecca Rosenke; Dana Scott; Ann Hawkinson; Emmie de Wit; Tony Schountz; Richard A Bowen
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

5.  Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China.

Authors:  Wenling Wang; Huijuan Wang; Yao Deng; Tie Song; Jiaming Lan; Guizhen Wu; Changwen Ke; Wenjie Tan
Journal:  Emerg Microbes Infect       Date:  2016-11-09       Impact factor: 7.163

6.  Development and Validation of a Serologic Test Panel for Detection of Powassan Virus Infection in U.S. Patients Residing in Regions Where Lyme Disease Is Endemic.

Authors:  Angela M Thomm; Anna M Schotthoefer; Alan P Dupuis; Laura D Kramer; Holly M Frost; Thomas R Fritsche; Yvette A Harrington; Konstance K Knox; Sue C Kehl
Journal:  mSphere       Date:  2018-01-10       Impact factor: 4.389

7.  Risk factors for MERS coronavirus infection in dromedary camels in Burkina Faso, Ethiopia, and Morocco, 2015.

Authors:  Eve Miguel; Véronique Chevalier; Gelagay Ayelet; Med Nadir Ben Bencheikh; Hiver Boussini; Daniel Kw Chu; Ikhlass El Berbri; Ouaffa Fassi-Fihri; Bernard Faye; Getnet Fekadu; Vladimir Grosbois; Bryan Cy Ng; Ranawaka Apm Perera; T Y So; Amadou Traore; François Roger; Malik Peiris
Journal:  Euro Surveill       Date:  2017-03-30

8.  MERS-CoV Antibodies in Humans, Africa, 2013-2014.

Authors:  Anne Liljander; Benjamin Meyer; Joerg Jores; Marcel A Müller; Erik Lattwein; Ian Njeru; Bernard Bett; Christian Drosten; Victor Max Corman
Journal:  Emerg Infect Dis       Date:  2016-06-15       Impact factor: 6.883

9.  Lack of serological evidence of Middle East respiratory syndrome coronavirus infection in virus exposed camel abattoir workers in Nigeria, 2016.

Authors:  Ray Ty So; Ranawaka Apm Perera; Jamiu O Oladipo; Daniel Kw Chu; Sulyman A Kuranga; Kin-Ho Chan; Eric Hy Lau; Samuel Ms Cheng; Leo Lm Poon; Richard J Webby; Malik Peiris
Journal:  Euro Surveill       Date:  2018-08

10.  Inclusion of MERS-spike protein ELISA in algorithm to determine serologic evidence of MERS-CoV infection.

Authors:  Suvang Trivedi; Congrong Miao; Mohammad M Al-Abdallat; Aktham Haddadin; Sultan Alqasrawi; Ibrahim Iblan; Mohannad A Nsour; Tarek Alsanouri; Sami S Ali; Brian Rha; Susan I Gerber; Daniel C Payne; Azaibi Tamin; Natalie J Thornburg
Journal:  J Med Virol       Date:  2017-09-26       Impact factor: 2.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.